证券代码：605088 证券简称：冠盛股份 公告编号：2026-009 温州市冠盛汽车零部件集团股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/4/11 | | | | | | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 年 月 月 2025 4 4 | 10 | 日~2026 | 年 | 日 9 | | 预计回购金额 | 8,000万元~12,000万元 | | | | | | 回购价格上限 | 55.45元/股 | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 □用于转换公司可转债 | | | | | | | □为维护公司价值及股东权益 | | | | | | 实际回购股数 | 2,654,716股 | | | | | | 实际回购股数占总股本比例 | 1.3095% | | | | | | 实际回购金额 | 10,021.09万元 ...

证券代码：605088 证券简称：冠盛股份 公告编号：2026-008 温州市冠盛汽车零部件集团股份有限公司 关于以集中竞价交易方式回购股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 体内容详见公司于 2025 年 6 月 12 日在上海证券交易所网站（www.sse.com.cn）披 露的《关于以集中竞价交易方式回购股份的预案》（公告编号：2025-048）。 二、回购股份的进展情况 根据《上市公司股份回购规则》及《上海证券交易所上市公司自律监管指引 第 7 号——回购股份》的相关规定，在回购股份期间，上市公司应当在每个月的 前 3 个交易日内披露截至上月末的回购进展情况。现将公司截至上月末的回购股 份情况公告如下： 2026 年 2 月，公司未实施回购。截至 2026 年 2 月 28 日，公司已累计回购股 份 2,181,200 股，占公司总股本（即 202,726,053 股）的比例为 1.0759%，购买的最 高价为 41.10 元/股，最低价为 34.12 元/股，已支付的总金额为 83,992,8 ...

证券代码：605088 证券简称：冠盛股份 公告编号：2026-007 温州市冠盛汽车零部件集团股份有限公司 关于上证 E 互动有关问题回复的说明公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 温州市冠盛汽车零部件集团股份有限公司（以下简称"公司"）于近日在上 证 E 互动平台就投资者关于固液混合电池产线订单和机器人业务订单的问题做 出回复，为保障广大投资者的合法权益，公司就相关业务情况补充说明，并进行 进一步风险提示： 一、E 互动回复相关情况的说明 针对以上回复做进一步说明如下：子公司浙江冠盛东驰能源科技有限公司 （以下简称"冠盛东驰"）投资建设的固液混合电池项目产品并非固态电池，不 适于新能源汽车领域。目前固液电池量产线还未下线，冠盛东驰 2025 年度实现 营业收入 403.30 万元，占 2025 年度公司营业收入的 0.09%，实现净利润 -2,347.69 万元，以上数据未经审计，对公司的影响极小。公司将根据具体合作 业务的开展情况，及时履行信息披露义务，敬请投资者留意投资风险。 2、机器人业务相关回 ...

Group 1 - Fangda Carbon plans to acquire 100% equity of Tianjin Tongda Huanyu Logistics Co., Ltd. for 319 million yuan [1] - Xiamen Tungsten intends to acquire 39% equity of Jiujiang Dadi Mining Development Co., Ltd. and has signed an intention agreement with a transferor [6] - Wenkai Co. has won a bid for a landscape project worth 50.8162 million yuan [7] Group 2 - Changchun High-tech's subsidiary Jin Sai Pharmaceutical received approval for a clinical trial application for GenSci136, a treatment for IgA nephropathy [3] - China National Pharmaceutical has received drug registration certificates for fumaric acid volnoral tablets, used for treating reflux esophagitis [12] - Zhenhua Group plans to issue convertible bonds not exceeding 1.2 billion yuan [26] Group 3 - CSG Holding's stock may undergo a control change due to share pledge judicial transfer [30] - Ningbo Yunsheng plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [19] - Keda Guochuang's controlling shareholder intends to transfer 5% of the company's shares through an agreement [28] Group 4 - A number of companies, including Finer Pharma, Yixing Guoyuan Investment, and others, have announced plans to reduce their shareholdings by various percentages [2][4][9][11][15][16][20][21][22][23][25][29] - Highweida plans to repurchase shares worth 30 to 35 million yuan [17] - ST Zhongzhu is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [24] Group 5 - A number of companies, including Jiekang Equipment and others, have faced legal issues or penalties [27][40] - Aclaris Therapeutics has clarified that reports regarding its robotic products entering mass production were misinterpreted [41]

Clarifications - Guansheng Co. clarified that its core product, the intelligent bionic joint arm, currently has no orders and has not generated operating income, stating that media reports were misinterpretations [1] - Haiguang Information indicated that its business layout does not currently involve TPU chips and remains focused on core strategic products [1] Shareholding Reductions - Shareholders of Congsheng Co. plan to collectively reduce no more than 5% of the company's shares, with the controlling shareholder and actual controller Wang Zongyou and Tian Niabin planning to reduce a combined total of no more than 3.00%, and other specific shareholders planning to reduce 1.63% and 0.37% respectively [2] - Xinling Electric's director and general manager Zhang Pengchun plans to reduce no more than 1.28% of the company's total shares within three months after the announcement [2] - Senba Sensor's shareholder Ganzhou Yingbei Investment Development Co., Ltd. plans to reduce no more than 3% of the company's total shares [3] - Changchuan Technology's actual controller's concerted action partner plans to reduce no more than 1.1128% of the company's total shares through block trading [2] - GCL-Poly Energy's shareholder Shenzhen Qianhai Oriental Entrepreneurship Financial Holdings Co., Ltd. plans to reduce no more than 1.01% of the company's total shares within three months after the announcement [2] Performance Reports - AVIC Optoelectronics released a preliminary report for 2025, indicating a net profit attributable to shareholders of 2.124 billion yuan, a year-on-year decrease of 36.69% [4] - ST Jinglan announced an expected significant decline in operating performance for 2025, with its stock trading experiencing severe abnormal fluctuations [4] Other News - Jieqiang Equipment and its actual controller Pan Feng were convicted of unit bribery, with the company fined 1.5 million yuan and Pan Feng sentenced to one year and nine months in prison, along with a fine of 1.5 million yuan [5] - ST Cuihua is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure [5] - Wentai Technology and Luxshare ICT are in dispute over the performance of an agreement regarding an asset package in India, with the matter submitted to the Singapore International Arbitration Centre [5] - Sunrock Electronics filed a lawsuit against Murata Manufacturing Co., Ltd. for malicious intellectual property litigation, seeking compensation of 1.5 million yuan for economic losses incurred [5] - ST Jieneng is undergoing judicial transfer procedures for pledged shares, which may lead to a change in company control, with stock suspension starting from February 10, 2026 [5] - Yutai Micro's shareholder agreement has expired, resulting in a change in actual control from Shi Qing and Ouyang Yufei to no actual controller [5]

Group 1 - Xi Jinping emphasized the importance of technological self-reliance for building a modern socialist country during his visit to the National Innovation Park in Beijing, where he observed advancements in AI and robotics [1] - The Shanghai, Shenzhen, and Beijing stock exchanges announced a package of measures to optimize refinancing processes for high-quality listed companies, aiming to enhance refinancing efficiency [2] - The Ministry of Commerce plans to implement a vehicle trade-in program by 2026 to boost automotive consumption, alongside other reforms in the automotive circulation sector [3] Group 2 - Zhongke Shuguang announced plans to issue convertible bonds to raise up to 8 billion yuan for advanced computing cluster projects focused on AI [5] - Efort plans to acquire 100% of Shengpu shares, with stock resuming trading on February 10; Hainan Mining intends to acquire 69.9% of Fengrui Fluorine Industry shares, also resuming trading [6] - Jinhui shares announced a 210 million yuan acquisition of 100% of Fusheng Mining, which holds a gold mining license with an annual production capacity of 50,000 tons [6] Group 3 - Mengguli announced an investment of 929 million yuan to build a project for producing 30,000 tons of lithium-ion battery cathode materials annually [7] - Yuanjie Technology plans to invest 1.251 billion yuan in the second phase of a semiconductor chip and device R&D production base, focusing on high-speed optical chips [7] - Cuihua Jewelry is under investigation by the CSRC for suspected violations of information disclosure regulations [8] Group 4 - The transportation regulatory office conducted a meeting with Gaode Dache, highlighting issues such as inadequate management of partner ride-hailing platforms and improper emergency responses [13] - The U.S. stock market saw gains, with major indices rising, particularly Oracle, which increased by over 9% [14] - COMEX gold futures rose by 2.1% to $5084.2 per ounce, while silver futures increased by 8% to $83.05 per ounce [15]

Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are inaccurate and misinterpret its statements [1] Group 1: Company Operations - The company's main business remains focused on the research, development, production, and sales of automotive chassis system components [1] - There are currently no orders or generated revenue from the company's intelligent bionic joint arm products [1] Group 2: Media Misinterpretation - The media reports incorrectly stated that the intelligent bionic joint arm products have entered the mass production stage and that there are over a thousand intended orders in the biopharmaceutical experimental equipment sector [1] - The company emphasizes that the intelligent bionic joint arm products have not yet reached mass production and that significant progress is still required before this can occur [1]

Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are inaccurate and misinterpreted [1] Group 1: Company Operations - The company's main business remains focused on the research, production, and sales of automotive chassis system components [1] - There are currently no orders or generated revenue from the intelligent bionic joint arm products [1] Group 2: Media Misinterpretation - The media reports incorrectly stated that the intelligent bionic joint arm product has received over a thousand order intentions in the biopharmaceutical experimental equipment sector [1] - The company emphasizes that the intelligent bionic joint arm product has not yet entered the mass production stage and is still far from achieving it [1]

公司主营业务未发生变更，仍以汽车底盘系统零部件的研发、生产和 销售为主要业务，当前机器人智能仿生关节臂产品无订单且未产生营业收 入。相关媒体报道措辞不准确，产品未进入量产阶段且距离量产还存在很 长的一段距离。后续若触及信息披露标准，将严格按照相关法律法规的规 定履行信息披露义务。 二、相关风险提示 证券代码：605088 证券简称：冠盛股份 公告编号：2026-006 温州市冠盛汽车零部件集团股份有限公司 关于媒体报道的澄清公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 近日，温州市冠盛汽车零部件集团股份有限公司关注到网上有个别媒 体发布了关于"冠盛股份在沪发布智能仿生关节臂"的相关报道。公司知 悉后高度重视，为避免相关信息对广大投资者造成误导，对有关情况进行 了核实，现予以澄清说明。 一、澄清声明 近日，温州市冠盛汽车零部件集团股份有限公司（以下简称"公司"） 关注到网上有个别媒体发布了关于"冠盛股份在沪发布智能仿生关节臂" 的相关报道，报道中提到公司人形机器人核心部件业务迈入商业量产阶段， 公司 ...

Core Viewpoint - The company clarifies that recent media reports regarding its humanoid robot core component business entering commercial production are based on misinterpretation, emphasizing that its main business remains automotive chassis system components and that there are currently no orders or revenue from the robotic products [1] Group 1 - The company announced that it will contact media outlets to request the removal of false statements and pursue accountability for the misinformation [1] - Since January 1, 2026, the company's stock has increased by 16.07%, outperforming both the industry and the Shanghai Composite Index during the same period [1] - The company advises investors to remain cautious regarding potential risks associated with the misinformation [1]